Add this topic to your myFT Digest for news straight to your inbox
A process that once cost $1bn is likely to fall to tens of dollars within a few years
Productive public spending leads to growth, as illustrated by the US, writes Mariana Mazzucato
A brilliant exploration of new ideas in business argues that government is behind the boldest risks and biggest breakthroughs
‘My daughters recoiled in shock when they were told their devices were banned,’ writes Gillian Tett
Re-engineering a familiar ingredient and the discovery of new compounds mark big steps in fighting the disease, writes Clive Cookson
FT Series: How financial pressures are affecting US research capacity
The scramble to ensure scientific work can proceed without falling prey to accidental leaks or malevolent intent
The ‘Berlin Patient’ has become a living legend and inspired scientists to hunt for new solutions, says Clive Cookson
Students from India and China are finding it harder to stay in the US
The US navy’s grants have been behind 59 award-winning research projects in the past 59 years
There may be drug companies worth buying but predicting a sector recovery would be hubris
International Edition